Table 1.
Eligibility criteria.
| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| Population | General population or targeted population | NA |
| Intervention | Strategies prevention or control and treatment COVID-19 pandemic | Other interventions |
| Comparator | No Intervention, standard care or any other intervention | NA |
| Outcome | Incremental cost-effectiveness ratio(ICER), Incremental cost per quality-adjusted life years(QALY), Incremental cost per disability-adjusted life years(DALY), Net monetary benefit | Cost analysis studies(i.e., studies which measured or compared costs without health outcomes) or outcomes related to effectiveness only |
| Study design | Partial economic evaluations if both costs and outcomes of one intervention, were considered | conference abstracts, review articles, animal studies and is do not find the full text. |
| full economic evaluation studies CEA, CUA or CBA (model-based or trial based) | ||
| Context | No restrictions | NA |
| Language | English language | NA |
CEA: cost-effectiveness analysis, CUA: cost-utility analysis, CBA: cost-benefit analysis.NA: not applicable.